NovoLog (Insulin Aspart) Onset, Peak, Duration, and Dosing Tips
NovoLog (insulin aspart) is a rapid-acting insulin analog. Pharmacokinetics:
| Parameter | Typical Range |
|---|---|
| Onset | 10–20 minutes |
| Peak Effect | 1–3 hours |
| Duration | 3–5 hours |
Key Clinical Points
- Timing: Inject 0–15 minutes before meal (or immediately after if unsure of intake). Matches postprandial glucose rise.
- Dosing: Individualized: Carb ratio (e.g., 1 unit / 10–15g carb) + Correction factor (ISF: 1 unit drops BG ~50 mg/dL). Determined by endocrinologist/CDE.
- Variability: Injection site (abdomen fastest), temperature, exercise, lipohypertrophy, dose size, individual kinetics.
- Pump Use: Standard rapid-acting for CSII.
- Hypoglycemia Risk: Highest at peak (1–3h). Treat <70 mg/dL: 15g fast carb, recheck 15 min.
- Compatibility: Do not mix with other insulins in same syringe (except NPH if drawn first — but rarely done now).
Adjuncts
- CGM (Dexcom, Libre, Guardian): Real-time glucose → proactive dosing.
- Smart Pens / Apps: Dose calculator, bolus tracking, insulin-on-board (IOB).
Work closely with your diabetes team. "Textbook" times are averages; your data defines your regimen.
Diabetes - Related Articles
- Weakness in Diabetes: High and Low Blood Sugar Effects
- Insulin Pump Comparison: A Comprehensive Guide for Diabetes Management
- Insulin Dosing and Diabetic Coma: Critical Medical Disclaimer
- Understanding the Chemistry of Diabetes: Types, Causes & Mechanisms
- Understanding Type 1 & 2 Diabetes: Symptoms and Key Facts
- Lantus OptiClik Pen: A Comprehensive Guide for Diabetics
- Fundraising Ideas for the American Diabetes Walk | [Organization Name]
